Last updated on February 2018

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Brief description of study

This is an randomized trial to evaluate the potential benefit of erythropoietin in the treatment of anemia in patients with lymphoma after autologous hematopoietic stem cell transplantation.

Detailed Study Description

Lymphoma patients with anemia on day +15 post-transplant will be randomized to erythropoietin group or control group. Potential benefit of erythropoietin will be evaluatedon day +60 post-transplant.

Clinical Study Identifier: NCT03010579

Find a site near you

Start Over